A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAvsar, Erol
dc.contributor.authorTiftikci, Arzu
dc.contributor.authorPoturoglu, Sule
dc.contributor.authorErzin, Yusuf
dc.contributor.authorKocakaya, Ozan
dc.contributor.authorDincer, Dinc
dc.contributor.authorYildirim, Bulut
dc.contributor.authorGuliter, Sefa
dc.contributor.authorTurkay, Cansel
dc.contributor.authorYilmaz, Ugur
dc.contributor.authorOnuk, Mehmet Derya
dc.contributor.authorBolukbas, Cengiz
dc.contributor.authorEllidokuz, Ender
dc.contributor.authorBektas, Ahmet
dc.contributor.authorTasan, Guralp
dc.contributor.authorAytug, Necip
dc.contributor.authorAtes, Yuksel
dc.contributor.authorKaymakoglu, Sabahattin
dc.date.accessioned2025-10-16T15:34:16Z
dc.date.issued2013
dc.identifier.doi10.4318/tjg.2013.0509
dc.identifier.otherWOS:000326481900003
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9345
dc.publisherTURKISH SOC GASTROENTEROLOGY
dc.sourceTURKISH JOURNAL OF GASTROENTEROLOGY
dc.subjectRanitidine bismuth citrate
dc.subjectlansoprazole
dc.subjectHelicobacter pylori
dc.subjecteradication
dc.titleA multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS